日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Ulcerative colitis: signaling pathways, therapeutic targets and interventional strategies

溃疡性结肠炎:信号通路、治疗靶点和干预策略

Jia, Jinhao; Liu, Ying; Wang, Dan; Pan, Zhaohai; Zheng, Qiusheng; Lu, Jun; Liang, Chao; Li, Defang

Epigenetic memory of colitis promotes tumour growth.

结肠炎的表观遗传记忆促进肿瘤生长。

Nagaraja Surya, Ojeda-Miron Lety, Zhang Ruochi, Oreskovic Ena, Hock Conrad, Hu Yan, Zeve Daniel, Sharma Karina, Hyman Roni R, Zhang Qiming, Castillo Andrew, Breault David T, Yilmaz Ömer H, Buenrostro Jason D

Manganese oxide nanozyme-loaded CO-releasing halloysite nanotubes for remodeling colonic immune, microbiota, and intestinal barrier homeostasis with concurrent pain relief in ulcerative colitis

负载氧化锰纳米酶的CO释放型埃洛石纳米管可用于重塑结肠免疫、微生物群和肠道屏障稳态,并同时缓解溃疡性结肠炎的疼痛

Zhang, He; Zhou, Linsa; Zhou, Qiang; Wen, Huiyun; Lu, Hongyang; Li, Jiayu; Yu, Li; Li, Hongyi; Zhu, Yinci; Xu, Mengzhu; Lu, Bin; Shi, Chengge; Zhang, Yanmei; Hu, Xiaowen; Shubhra, Quazi T H; He, Xiaosong; Cai, Xiaojun

GPX4-dependent ferroptosis governs ILC2 homeostasis and colitis progression.

GPX4 依赖性铁死亡控制 ILC2 的稳态和结肠炎的进展。

Liu Gaoyu, Wang Ying, Huang Huachen, Wang Jianye, Yang Jinhao, Wu Jingyi, Cao Hailong, Zhang Yuxin, Jing Yuchao, Zhou Pan, Yu Ying, Chen Chun, Liu Qiang, Zhou Jie

Viral mimicry acts as a tumor suppressor in colitis

病毒拟态在结肠炎中发挥肿瘤抑制作用

Larsen, Frederikke; Jeong, Will; Schep, Daniel; Good, Hayley J; Shin, Alice E; Zhang, Liyue; Derouet, Mathieu F; Wang, Timothy C; Castellani, Christina A; Shooshtari, Parisa; Asfaha, Samuel

Targeting NAT10 alleviates colonic senescence and elderly-onset colitis by disrupting N4-acetylation of DYRK1A.

靶向 NAT10 可破坏 DYRK1A 的 N4-乙酰化,从而缓解结肠衰老和老年性结肠炎。

Chen Jingyu, Xue Meng, Mi Shuyi, Fu Anbo, Chen Wenwen, Sun Yuhao, Xia Shenglong, Ge Qiwei, Luo Jiakai, Yu Qiao, Wang Liangjing, Chen Shujie

Surface hydrophobicity and rigidity determines protein corona on orally delivered nanoparticles treating colitis.

表面疏水性和刚性决定了口服纳米颗粒治疗结肠炎时表面的蛋白质冠层。

Wu Jiawei, Ni Mingjie, Xing Liyun, Wang Yating, Liu Xi, Zheng Yaxian, Li Lian, Huang Yuan

TIGAR regulates intestinal mucus barrier integrity by inhibiting lactylation of G6PD/6PGD in ulcerative colitis.

TIGAR 通过抑制溃疡性结肠炎中 G6PD/6PGD 的乳酸化来调节肠道粘液屏障的完整性。

Wu Dan, Su Sen, Zhang Panyang, Zha Xule, Wei Yan, Zhang Ting, Liu Xiaoyan, Chen Qian, Li Chunyan, Huang Qianying, Zhou Zhihao, Yang Yan, Xia Lin, Fan Shijun, Peng Xi

A microbiota-IPA axis facilitates intestinal stem cell-mediated regeneration in colitis through a Hopx-associated program.

微生物群-IPA轴通过Hopx相关程序促进结肠炎中肠道干细胞介导的再生。

Zhang Yanan, Meng Jinxin, Tu Shuyu, Ma Linlin, Zhao Xinya, Gao Jinsong, Wu Jianan, Xu Weilv, Chen Shuxian, Cheng Hairong, Zhang Li, Zhu Shu Jeffrey

Microbiota-derived IPA protects against colitis by regulating intestinal HMGCS2-mediated ketogenesis to facilitate mucosal healing.

微生物群衍生的IPA通过调节肠道HMGCS2介导的酮生成来促进粘膜愈合,从而起到预防结肠炎的作用。

Zhang Yanan, Tu Shuyu, Shao Xian, Meng Jinxin, Zhang Zhuobiao, Wei Wei, Jing Xuping, Qin Zhewen, Wu Jianan, Xu Weilv, Dong Bofei, Gao Jinsong, Qu Aijuan, Chen Shuxian, Zhang Li, Gong Peng, Shan Bo, Shi Hui, Zhu Shu Jeffrey